AnaptysBio, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 57
EBIT TTM (mln): -128
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 5 16 18 17 10 5 8 75 63 10 17 91
Przychód Δ r/r 0.0% 188.9% 10.9% -5.0% -40.1% -50.0% 60.0% 837.5% -15.8% -83.7% 66.8% 432.0%
Marża brutto 100.0% 100.0% 100.0% 7.6% -194.4% 100.0% -1141.7% -6.7% -55.9% 77.3% 86.2% 100.0%
EBIT (mln) -5 5 -3 -3 -29 -67 -107 -24 -57 -115 -164 -115
EBIT Δ r/r 0.0% -192.1% -168.2% -8.9% 851.4% 131.8% 61.0% -77.8% 137.9% 102.7% 42.8% -30.1%
EBIT (%) -96.4% 30.7% -18.9% -18.1% -287.8% -1334.4% -1342.9% -31.8% -89.9% -1119.4% -958.3% -125.9%
Koszty finansowe (mln) 1 1 0 0 2 2 1 0 1 21 18 50
EBITDA (mln) -5 5 -3 -4 -28 -60 -96 -19 -56 -108 -136 -93
EBITDA(%) -85.8% 32.7% -18.5% -18.3% -269.3% -1203.9% -1205.6% -25.8% -89.2% -1045.9% -791.7% -101.6%
Podatek (mln) 1 1 0 0 2 -0 -0 -0 -1 0 -0 0
Zysk Netto (mln) -6 4 -5 -4 -30 -62 -97 -20 -57 -129 -164 -145
Zysk netto Δ r/r 0.0% -163.7% -253.0% -21.2% 606.0% 105.0% 57.9% -79.5% 187.1% 125.1% 27.1% -11.2%
Zysk netto (%) -101.1% 22.3% -30.8% -25.5% -300.7% -1233.1% -1216.7% -26.6% -90.5% -1251.3% -953.7% -159.1%
EPS -0.0948 0.0164 -0.38 -0.23 -1.52 -2.5 -3.6 -0.73 -2.08 -4.57 -6.08 -5.12
EPS (rozwodnione) -0.0928 0.0155 -0.36 -0.23 -1.52 -2.5 -3.6 -0.73 -2.08 -4.57 -6.08 -5.12
Ilośc akcji (mln) 58 14 14 18 20 25 27 27 27 28 27 28
Ważona ilośc akcji (mln) 60 15 15 18 20 25 27 27 27 28 27 28
Waluta USD USD USD USD USD USD USD USD USD USD USD USD